10 20 30 40 50 60 70 80 1DOJ - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HYDROLASE/HYDROLASE INHIBITOR 21-DEC-99 1DOJ
TITLE CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN*RWJ-51438 COMPLEX AT 1.7 A
COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-THROMBIN; COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.21.5; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: HIRUGEN; COMPND 7 CHAIN: B; COMPND 8 FRAGMENT: FRAGMENT OF HIRUDIN; COMPND 9 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELLULAR_LOCATION: PLASMA; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES; SOURCE 8 OTHER_DETAILS: HIRUGEN, COMES FROM HIRUDIN
KEYWDS THROMBIN, SERINE PROTEASE, ENZYME INHIBITION, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR R.RECACHA,M.J.COSTANZO,B.E.MARYANOFF,M.CARSON,L.DELUCAS, AUTHOR 2 D.CHATTOPADHYAY
REVDAT 4 13-JUL-11 1DOJ 1 VERSN REVDAT 3 24-FEB-09 1DOJ 1 VERSN REVDAT 2 01-APR-03 1DOJ 1 JRNL REVDAT 1 03-NOV-00 1DOJ 0
JRNL AUTH R.RECACHA,M.J.COSTANZO,B.E.MARYANOFF,M.CARSON,L.DELUCAS, JRNL AUTH 2 D.CHATTOPADHYAY JRNL TITL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITH RWJ-51438 JRNL TITL 2 AT 1.7 A: UNUSUAL PERTURBATION OF THE 60A-60I INSERTION JRNL TITL 3 LOOP. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 56 1395 2000 JRNL REFN ISSN 0907-4449 JRNL PMID 11053836 JRNL DOI 10.1107/S0907444900010763
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH X.QIU,K.P.PADMANABHAN,V.E.CARPEROS,A.TULINSKY,T.KLINE, REMARK 1 AUTH 2 J.M.MARAGANORE,J.W.FENTON II REMARK 1 TITL STRUCTURE OF THE HIRULOG 3-THROMBIN COMPLEX AND NATURE OF REMARK 1 TITL 2 THE S' SUBSITES OF SUBSTRATES AND INHIBITORS REMARK 1 REF BIOCHEMISTRY V. 31 11689 1992 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.H.MATTHEWS,R.KRISHNAN,M.J.COSTANZO,B.E.MARYANOFF, REMARK 1 AUTH 2 A.TULINSKY REMARK 1 TITL CRYSTAL STRUCTURE OF THROMBIN WITH THIAZOLE-CONTAINING REMARK 1 TITL 2 INHIBITORS: PROBES OF THE S1' BINDING SITE REMARK 1 REF BIOPHYS.J. V. 71 2830 1996 REMARK 1 REFN ISSN 0006-3495 REMARK 1 REFERENCE 3 REMARK 1 AUTH W.BODE,D.TURK,A.KARSHIKOV REMARK 1 TITL THE REFINED 1.9-A X-RAY CRYSTAL STRUCTURE OF D-PRO-PHE-ARG REMARK 1 TITL 2 CHLOROMETHYLKETONE-INHIBITED HUMAN ALPHA-THROMBIN: STRUCTURE REMARK 1 TITL 3 ANALYSIS, OVERALL STRUCTURE, ELECTROSTATIC PROPERTIES, REMARK 1 TITL 4 DETAILED ACTIVE-SITE GEOMETRY, AND STRUCTURE-FUNCTION REMARK 1 TITL 5 RELATIONSHIPS REMARK 1 REF PROTEIN SCI. V. 1 426 1992 REMARK 1 REFN ISSN 0961-8368
REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 3.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1520225.350 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 84.2 REMARK 3 NUMBER OF REFLECTIONS : 33357 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3322 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.81 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 56.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3311 REMARK 3 BIN R VALUE (WORKING SET) : 0.2760 REMARK 3 BIN FREE R VALUE : 0.2980 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 3670 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2452 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 349 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.02000 REMARK 3 B22 (A**2) : -1.45000 REMARK 3 B33 (A**2) : 0.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : 0.13 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.16 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.40 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.61 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.400 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.060 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.420 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.480 ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : INH3.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : NAG.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : TOPH19.SOL REMARK 3 TOPOLOGY FILE 3 : INH2.TOP REMARK 3 TOPOLOGY FILE 4 : NAG.TOP REMARK 3 TOPOLOGY FILE 5 : SULF.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE BIJVOET DIFFERENCES WERE USED IN REMARK 3 PHASING
REMARK 4 REMARK 4 1DOJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-JAN-00. REMARK 100 THE RCSB ID CODE IS RCSB010249.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-MAR-98 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 126549 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.660 REMARK 200 RESOLUTION RANGE LOW (A) : 99.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.1 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.66 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : 87.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.20000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.75 SODIUM ACETATE, 0.01% (W/V), 20% REMARK 280 POLYETHYLENE GLYCOL 4000 (W/V), PH 6.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 295.0K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 31.49100 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 58.76050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.49100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 58.76050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 14L REMARK 465 ARG A 15
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 1H OG1 CG2 REMARK 470 PHE A 1G CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP A 14M CB CG OD1 OD2 REMARK 470 GLU A 247 CG CD OE1 OE2
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 1G -15.98 -144.81 REMARK 500 PHE A 7 -86.97 -132.94 REMARK 500 ASN A 60G 84.37 -163.05 REMARK 500 HIS A 71 -57.54 -130.71 REMARK 500 ILE A 79 -57.99 -120.15 REMARK 500 GLU A 97A -69.60 -107.42 REMARK 500 SER A 214 -69.79 -109.61 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 972 DISTANCE = 5.16 ANGSTROMS
REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 301 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 LYS A 169 O REMARK 620 2 THR A 172 O 63.8 REMARK 620 3 ILE A 174 O 143.0 91.4 REMARK 620 4 HOH A 684 O 121.6 164.7 89.8 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 300 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ARG A 221A O REMARK 620 2 LYS A 224 O 90.4 REMARK 620 3 HOH A 595 O 90.0 93.4 REMARK 620 4 HOH A 714 O 110.8 158.8 88.3 REMARK 620 5 HOH A 713 O 95.1 81.3 172.7 94.8 REMARK 620 6 HOH A 531 O 157.7 68.3 85.2 90.8 88.2 REMARK 620 N 1 2 3 4 5
REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: N-METHYL-D-PHENYLALANYL-N-{(1S)-4-CARBAMIMIDAMIDO- REMARK 630 1-[(6-CARBOXY-1,3-BENZOTHIAZOL-2-YL)CARBONYL]BUTYL}-L-PROLINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 1Z0 A 401 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: ZAE PRO AR2 REMARK 630 DETAILS: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1Z0 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 250 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 301
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ABJ RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH D-PHE-PRO-ARG REMARK 900 CHLOROMETHYLKETONE (PPACK)
DBREF 1DOJ A 1H 247 UNP P00734 THRB_HUMAN 328 622 DBREF 1DOJ B 355 365 UNP P09945 HIRV2_HIRME 62 72
SEQRES 1 A 295 THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO SEQRES 2 A 295 LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG SEQRES 3 A 295 GLU LEU LEU GLU SER TYR ILE ASP GLY ARG ILE VAL GLU SEQRES 4 A 295 GLY SER ASP ALA GLU ILE GLY MET SER PRO TRP GLN VAL SEQRES 5 A 295 MET LEU PHE ARG LYS SER PRO GLN GLU LEU LEU CYS GLY SEQRES 6 A 295 ALA SER LEU ILE SER ASP ARG TRP VAL LEU THR ALA ALA SEQRES 7 A 295 HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS ASN PHE THR SEQRES 8 A 295 GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS HIS SER ARG SEQRES 9 A 295 THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SER MET LEU SEQRES 10 A 295 GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN TRP ARG GLU SEQRES 11 A 295 ASN LEU ASP ARG ASP ILE ALA LEU MET LYS LEU LYS LYS SEQRES 12 A 295 PRO VAL ALA PHE SER ASP TYR ILE HIS PRO VAL CYS LEU SEQRES 13 A 295 PRO ASP ARG GLU THR ALA ALA SER LEU LEU GLN ALA GLY SEQRES 14 A 295 TYR LYS GLY ARG VAL THR GLY TRP GLY ASN LEU LYS GLU SEQRES 15 A 295 THR TRP THR ALA ASN VAL GLY LYS GLY GLN PRO SER VAL SEQRES 16 A 295 LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU ARG PRO VAL SEQRES 17 A 295 CYS LYS ASP SER THR ARG ILE ARG ILE THR ASP ASN MET SEQRES 18 A 295 PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY LYS ARG GLY SEQRES 19 A 295 ASP ALA CYS GLU GLY ASP SER GLY GLY PRO PHE VAL MET SEQRES 20 A 295 LYS SER PRO PHE ASN ASN ARG TRP TYR GLN MET GLY ILE SEQRES 21 A 295 VAL SER TRP GLY GLU GLY CYS ASP ARG ASP GLY LYS TYR SEQRES 22 A 295 GLY PHE TYR THR HIS VAL PHE ARG LEU LYS LYS TRP ILE SEQRES 23 A 295 GLN LYS VAL ILE ASP GLN PHE GLY GLU SEQRES 1 B 11 ASP PHE GLU GLU ILE PRO GLU GLU TYS LEU GLN
MODRES 1DOJ ASN A 60G ASN GLYCOSYLATION SITE MODRES 1DOJ TYS B 363 TYR O-SULFO-L-TYROSINE
HET TYS B 363 16 HET 1Z0 A 401 42 HET NAG A 250 14 HET NA A 300 1 HET NA A 301 1
HETNAM TYS O-SULFO-L-TYROSINE HETNAM 1Z0 N-METHYL-D-PHENYLALANYL-N-{(1S)-4-CARBAMIMIDAMIDO-1- HETNAM 2 1Z0 [(6-CARBOXY-1,3-BENZOTHIAZOL-2-YL)CARBONYL]BUTYL}-L- HETNAM 3 1Z0 PROLINAMIDE HETNAM NAG N-ACETYL-D-GLUCOSAMINE HETNAM NA SODIUM ION
HETSYN 1Z0 RWJ-51438
FORMUL 2 TYS C9 H11 N O6 S FORMUL 3 1Z0 C29 H35 N7 O5 S FORMUL 4 NAG C8 H15 N O6 FORMUL 5 NA 2(NA 1+) FORMUL 7 HOH *349(H2 O)
HELIX 1 1 PHE A 7 SER A 11 5 5 HELIX 2 3 ALA A 55 LEU A 59 1 5 HELIX 3 5 ASP A 125 LEU A 130 1 9 HELIX 4 6 GLU A 164 SER A 171 1 8 HELIX 5 8 VAL A 231 PHE A 245 1 15
SHEET 1 A 7 SER A 20 ASP A 21 0 SHEET 2 A 7 GLN A 156 PRO A 161 -1 N VAL A 157 O SER A 20 SHEET 3 A 7 LYS A 135 GLY A 140 -1 N GLY A 136 O LEU A 160 SHEET 4 A 7 PRO A 198 LYS A 202 -1 O PRO A 198 N THR A 139 SHEET 5 A 7 TRP A 207 TRP A 215 -1 N TYR A 208 O MET A 201 SHEET 6 A 7 GLY A 226 HIS A 230 -1 N PHE A 227 O TRP A 215 SHEET 7 A 7 MET A 180 ALA A 183 -1 O PHE A 181 N TYR A 228 SHEET 1 B 7 GLN A 30 ARG A 35 0 SHEET 2 B 7 GLU A 39 LEU A 46 -1 O GLU A 39 N ARG A 35 SHEET 3 B 7 TRP A 51 THR A 54 -1 N LEU A 53 O SER A 45 SHEET 4 B 7 ALA A 104 LEU A 108 -1 N ALA A 104 O THR A 54 SHEET 5 B 7 LYS A 81 ILE A 90 -1 N GLU A 86 O LYS A 107 SHEET 6 B 7 LEU A 64 ILE A 68 -1 O LEU A 64 N LEU A 85 SHEET 7 B 7 GLN A 30 ARG A 35 -1 O MET A 32 N ARG A 67
SSBOND 1 CYS A 1 CYS A 122 1555 1555 2.03 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.03 SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.03 SSBOND 4 CYS A 191 CYS A 220 1555 1555 2.03
LINK ND2 ASN A 60G C1 NAG A 250 1555 1555 1.46 LINK C GLU B 362 N TYS B 363 1555 1555 1.33 LINK C TYS B 363 N LEU B 364 1555 1555 1.33 LINK O LYS A 169 NA NA A 301 1555 1555 2.81 LINK O THR A 172 NA NA A 301 1555 1555 2.74 LINK O ILE A 174 NA NA A 301 1555 1555 2.73 LINK O ARG A 221A NA NA A 300 1555 1555 2.40 LINK O LYS A 224 NA NA A 300 1555 1555 2.47 LINK NA NA A 300 O HOH A 595 1555 1555 2.61 LINK NA NA A 300 O HOH A 714 1555 1555 2.51 LINK NA NA A 300 O HOH A 713 1555 1555 2.47 LINK NA NA A 300 O HOH A 531 1555 1555 2.63 LINK NA NA A 301 O HOH A 684 1555 1555 2.88 LINK OG SER A 195 C4 1Z0 A 401 1555 1555 1.42
CISPEP 1 SER A 36A PRO A 37 0 -0.07
SITE 1 AC1 24 HIS A 57 TYR A 60A TRP A 60D LYS A 60F SITE 2 AC1 24 GLU A 97A LEU A 99 ASP A 189 ALA A 190 SITE 3 AC1 24 CYS A 191 GLU A 192 GLY A 193 ASP A 194 SITE 4 AC1 24 SER A 195 SER A 214 TRP A 215 GLY A 216 SITE 5 AC1 24 GLY A 219 GLY A 226 LYS A 236 LYS A 240 SITE 6 AC1 24 HOH A 533 HOH A 589 HOH A 747 HOH A 963 SITE 1 AC2 4 ASN A 60G VAL A 149C HOH A 847 HOH A 902 SITE 1 AC3 6 ARG A 221A LYS A 224 HOH A 531 HOH A 595 SITE 2 AC3 6 HOH A 713 HOH A 714 SITE 1 AC4 5 LYS A 169 THR A 172 ILE A 174 ILE A 176 SITE 2 AC4 5 HOH A 684
CRYST1 62.982 117.521 47.989 90.00 90.00 90.00 P 21 21 2 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.015878 0.000000 0.000000 0.00000
SCALE2 0.000000 0.008509 0.000000 0.00000
SCALE3 0.000000 0.000000 0.020838 0.00000